Oxford BioMedica, Oxxon Therapeutics Ltd. deal

OXB will acquire Oxxon for 31.8 million shares, valuing the deal at £15.9 million ($31.1

Read the full 153 word article

How to gain access

Continue reading with a
two-week free trial.